Product Information
RANOLAZINE ER 500 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.1629 per EA under NDC 00904750604. Its NADAC has been published 62 times since Apr 23, 2025.
The Low Outlier badge above means this manufacturer's average price in the Ranolazine market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904750604
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RANOLAZINEApproval Type
Generic (ANDA)
FDA Application
ANDA209953On Market Since
1/17/2025
Pharmacological Classes
Price Statistics
The NADAC for RANOLAZINE ER 500 MG TABLET has been published 62 times since Apr 23, 2025, and over the history we have for it it has declined 21.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1629 per EA |
|---|---|
| All-time high | $0.2071 (Jun 11, 2025) |
| All-time low | $0.1624 (Feb 18, 2026) |
| 52-week high | $0.1976 |
| 52-week low | $0.1624 |
| Median price | $0.1677 |
| Average price | $0.1755 |
| Largest weekly change | -7.5% (Aug 20, 2025) |
| Weeks tracked | 62 |
| Tracking since | Apr 23, 2025 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RANOLAZINE ER 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RANOLAZINE ER 500 MG TABLET, manufactured by Major Pharmaceuticals, is $0.1629 per EA (NDC 00904750604), effective Jun 24, 2026.
How has the price of RANOLAZINE ER 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for RANOLAZINE ER 500 MG TABLET has declined 21.1%. It has been tracked across 62 weekly CMS publications since Apr 23, 2025.
What are the highest and lowest recorded NADAC prices for RANOLAZINE ER 500 MG TABLET?
Since Apr 23, 2025, the NADAC for RANOLAZINE ER 500 MG TABLET has ranged from a low of $0.1624 (Feb 18, 2026) to a high of $0.2071 (Jun 11, 2025), with a median of $0.1677 per EA.
Are there cheaper alternatives to RANOLAZINE ER 500 MG TABLET?
Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RANOLAZINE ER 500 MG TABLET, is $0.1624 per EA — about 0% below RANOLAZINE ER 500 MG TABLET.
Who manufactures RANOLAZINE ER 500 MG TABLET?
RANOLAZINE ER 500 MG TABLET (NDC 00904750604) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification